GlassScriptPhysician profile
John J Hall
NPI 1700132545
$4,392.11
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,627 · 2020: $98.79 · 2021: $562 · 2022: $35.12 · 2023: $69.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $69.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $69.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $1,341.62 | 2019-2021 | |
| Globus Medical, INC. | $1,156.27 | 2019 | |
| Medical Device Business Services, INC. | $936.26 | 2019 | |
| Intuitive Surgical, INC. | $483.49 | 2019 | |
| Apollo Endosurgery US INC | $196.54 | 2019 | |
| Davol INC. | $133.91 | 2020-2022 | |
| Kerecis Limited | $69.59 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Covidien LP | $19.34 | 2019 | |
| Allergan, INC. | $16.18 | 2021 | |
| W. L. Gore & Associates, INC. | $13.72 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.69 | 2019 | |
| Merck Sharp & Dohme LLC | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.